Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model. [electronic resource]
Producer: 20070320Description: 347-55 p. digitalISSN:- 1600-6135
- Amides -- pharmacology
- Animals
- Carcinoma, Hepatocellular -- physiopathology
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Enzyme Inhibitors -- pharmacology
- Immunosuppressive Agents -- pharmacology
- Intracellular Signaling Peptides and Proteins -- antagonists & inhibitors
- Liver Neoplasms, Experimental -- physiopathology
- Liver Transplantation
- Male
- Neoplasm Invasiveness -- physiopathology
- Neoplasm Recurrence, Local -- physiopathology
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Pyridines -- pharmacology
- Rats
- Rats, Inbred BUF
- Signal Transduction -- drug effects
- Tacrolimus -- pharmacology
- rho-Associated Kinases
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.